Hurvitz Chaim
SEC CIK 1630542 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | Dir | 570.0K | $1.05M | — | 3 | 2022-11-16 | 2023-08-30 |
Most active insiders at NRXP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| No open-market trades in the last year. | ||||
Hurvitz Chaim made no open-market trades at NRXP in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-11 | 2023-08-30 | NRXP | NRX Pharmaceuticals, Inc. | Hurvitz Chaim | Dir | P - Purchase | $0.29 | +70.0K | 570.0K | +14% | +$20.3K | |
| MA | 2022-11-23 | 2022-11-16+ | NRXP | NRX Pharmaceuticals, Inc. | Hurvitz Chaim | Dir | P - Purchase | $1.03 | +500.0K | 459.6K | New | +$514.9K |
| DM | 2022-11-21 | 2022-11-16+ | NRXP | NRX Pharmaceuticals, Inc. | Hurvitz Chaim | Dir | P - Purchase | $1.03 | +500.0K | 459.6K | New | +$514.9K |
Purchase Sale Sale after option exercise All abbreviations